Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,988 | -56,824 | -219,710 | -42,052 | -33,050 |
| Depreciation Amortization | 379 | 183 | 764 | 492 | 303 |
| Income taxes - deferred | N/A | N/A | -19,000 | N/A | N/A |
| Accounts receivable | -26,660 | 4,475 | 907 | 2,985 | 3,318 |
| Accounts payable and accrued liabilities | -290 | -633 | 2,834 | 36 | -49 |
| Other Working Capital | -38,447 | -6,369 | 4,971 | 8,881 | 8,915 |
| Other Operating Activity | 77,643 | 43,251 | 178,073 | 1,783 | 1,903 |
| Operating Cash Flow | $-30,363 | $-15,917 | $-51,161 | $-27,875 | $-18,660 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 28,254 | 28,254 | 28,254 |
| PPE Investments | -2,189 | -602 | -206 | -142 | -142 |
| Net Acquisitions | N/A | N/A | 6,561 | N/A | N/A |
| Investing Cash Flow | $-2,189 | $-602 | $34,609 | $28,112 | $28,112 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -27,457 | -27,457 | -2,586 |
| Common Stock Issued | 3,151 | 3,031 | 231 | 231 | 149 |
| Other Financing Activity | 40,000 | 40,000 | 14,081 | 0 | 0 |
| Financing Cash Flow | $43,151 | $43,031 | $-13,145 | $-27,226 | $-2,437 |
| Exchange Rate Effect | 9 | -5 | -53 | -69 | -49 |
| Beginning Cash Position | 78,288 | 78,288 | 108,038 | 108,038 | 108,038 |
| End Cash Position | 88,896 | 104,795 | 78,288 | 80,980 | 115,004 |
| Net Cash Flow | $10,608 | $26,507 | $-29,750 | $-27,058 | $6,966 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,363 | -15,917 | -51,161 | -27,875 | -18,660 |
| Capital Expenditure | -2,189 | -602 | -206 | -142 | -142 |
| Free Cash Flow | -32,552 | -16,519 | -51,367 | -28,017 | -18,802 |